Our latest publication detailing the development of bispecific antibodies that selectively kill T cell leukemias and lymphomas and do not harm the normal human T cells
Science Translational Medicine 2021
Mutations in RAS oncogene lead to cancer. We generated an antibody that specifically kills the cancer cells carrying the mutant p53 protein.
Science Immunology 2021